{
  "company": {
    "name": "DISCO Pharmaceuticals",
    "website": "https://discopharmaceuticals.com/",
    "record": "https://startuphistory.org/c/discopharmaceuticals.com"
  },
  "status": null,
  "history_since": "2026-11-05T13:30:45.286Z",
  "baseline": {
    "snapshot_id": "dc0bd204c70c650d5b0308b8833be1f50a72a306710af288be97cc4fbc697373",
    "observed_at": "2026-11-05T13:30:45.286Z",
    "headline": "The surfaceome company",
    "description": null,
    "evidence": "https://discopharma.de/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T13:30:45.286Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-05T13:30:45.286Z",
      "variants": [
        {
          "headline": "The surfaceome company",
          "subhead": null,
          "observed_at": "2026-11-05T13:30:45.286Z",
          "evidence": "https://discopharma.de/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "The surfaceome company",
      "subhead": null,
      "from": "2026-11-05T13:30:45.286Z",
      "to": "2026-11-05T13:30:45.286Z",
      "captures": 1,
      "evidence": "https://discopharma.de/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-05T13:30:45.286Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Stipple Bio",
      "record": "https://startuphistory.org/c/stipple.bio",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both map the tumor surfaceome to discover tumor-specific epitopes for targeted oncology therapeutics."
    },
    {
      "name": "Combotope Therapeutics",
      "record": "https://startuphistory.org/c/combotopetherapeutics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both discover tumor-selective cell-surface antibodies to enable ADCs and other targeted cancer biologics."
    },
    {
      "name": "Immuto Scientific",
      "record": "https://startuphistory.org/c/immutoscientific.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both use surfaceomics to map disease-specific surface proteins and epitopes for targeted therapeutic discovery."
    },
    {
      "name": "Oxford BioTherapeutics",
      "record": "https://startuphistory.org/c/oxfordbiotherapeutics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both use proprietary discovery platforms to identify cell-surface targets and develop ADC-based cancer therapies."
    },
    {
      "name": "Arda Therapeutics",
      "record": "https://startuphistory.org/c/ardatx.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both identify disease-driving cell-surface markers and design targeted biologic therapies against them."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “DISCO Pharmaceuticals” company record, https://startuphistory.org/c/discopharmaceuticals.com"
}